New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals ...

Tirzepatide discontinuation was associated with reduced cardiometabolic benefits especially among patients with body weight ...

Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide—a drug known as Zepbound—on weight ...

New animal research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals distinct metabolic adjustments to tirzepatide and semaglutide treatment, with ...

Over the past few years, a new class of injectable medications has changed the way obesity is treated. Two drugs—tirzepatide and semaglutide—have shown striking results in helping people lose weight ...

Investigators sourced data for this study from the TriNetX Analytics Research Network database. Patients (N=1,999,881) diagnosed with AF between 2022 and 2024 and who used tirzepatide for diabetes ...

It’s important to research a pharmacy before purchasing any compounded drugs. You can also ask a healthcare professional for their recommendations. Compounded tirzepatide has not undergone the ...

Some airlines are investing in SAF research, and in a few cases, production development. But the greatest boost airlines can give this nascent industry is still usage commitments and offtake ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference.

As research continues and coverage improves, tirzepatide may become a cornerstone of obesity care — but only if patients can afford to access it.

Tirzepatide and semaglutide are highly effective medications for obesity management. The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without type 2 ...